CAR-T

#CAR-T #Immunotherapy #Oncology

Collaboration aims to develop targeted, effective cancer immunotherapies

Immunai has joined forces with Baylor College of Medicine to bring more targeted and effective cancer therapies to market. Leveraging Immunai’s single-cell technology and artificial intelligence, Baylor and Immunai will analyse natural killer T (NKT) cells and genetically engineer them into immunotherapies that target a variety of cancers, including solid… Read More

#News

#Biologics / Biotechnology #CAR-T

Are you interested in reversing the state of T cell exhaustion?

If you are a biotech scientist interested in reversing or overcoming the state of T-cell exhaustion, this webinar will show you how advanced flow cytometry can be used to effectively evaluate immuno-oncology drugs using physiologically relevant assays. Quantifying T cell exhaustion: An insight into BiTE antibodies and CAR-T cells for improved… Read More

#News

#CAR-T #T-Cells

Flow cytometry in immuno-oncology: tools to evaluate potential drugs

Researchers are continually looking for processes and technology that give them the edge scientifically or commercially. If you are a biotech scientist interested in reversing or overcoming the state of T-cell exhaustion, this webinar will be beneficial to your work. Quantifying T cell exhaustion: An insight into BiTE antibodies… Read More

#News

#CAR-T #Sartorius #Webinar

Event provides insight for researchers into BiTE antibodies and CAR-T cells

If you are a biotech scientist interested in reversing or overcoming the state of T-cell exhaustion, this webinar will be of interest. Quantifying T cell exhaustion: An insight into BiTE antibodies and CAR-T cells for improved therapeutics will be hosted by DDW and presented by Sartorius. It will examine T cell… Read More

#News

#CAR-T #T-Cells

Quantifying T cell exhaustion: An insight into BiTE antibodies and CAR-T cells

This webinar looks at T cell exhaustion. This is recognised as a major challenge in the development of immuno-oncology therapies. Used to describe the loss of effector function due to chronic antigen exposure, it commonly occurs within the tumour microenvironment. This impairs the T cells’ ability to effectively eradicate cancerous… Read More

Webinar date:
Brought to you by Sartorius
#Webinars